Viewing Study NCT07043608


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-29 @ 3:15 PM
Study NCT ID: NCT07043608
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-02
First Post: 2025-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
Sponsor: Kelly Fitzgerald, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module